Trials / Unknown
UnknownNCT05351736
Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The present longitudinal study aims to investigate the impact of lurasidone treatment in recent-onset psychosis patients. The effects of lurasidone will be studied primarily in terms of structural and myelin modifications, in relation to clinical outcomes, before and after treatment and in healthy controls. Furthermore, neuropsychological tests will be used to evaluate changes in cognitive performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lurasidone | Treatment with lurasidone |
Timeline
- Start date
- 2022-01-26
- Primary completion
- 2024-01-28
- Completion
- 2024-04-28
- First posted
- 2022-04-28
- Last updated
- 2023-03-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05351736. Inclusion in this directory is not an endorsement.